drugset / Trial / NCT07398651
Apremilast and Adalimumab in Psoriatic Arthritis Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this work is to compare the efficacy of Apremilast combined with Methotrexate versus Adalimumab combined with Methotrexate
Timeline
- Start
- 2026-12-30
- Primary completion
- 2026-12-30
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adalimumab | Monoclonal antibody | — | — |
| Subject | Apremilast | Small molecule | — | — |